ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 21 Oct 2019
Last Applicant/ Owned by
Grafenauweg 6
Zug
CH
6300
Serial Number
86772159 filed on 29th Sep 2015
Registration Number
N/A
Correspondent Address
NICOLE K. MCLAUGHLIN
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LISOTUS
Medicinal, pharmaceutical and biopharmaceutical preparations for the treatment of diabetes; medicinal, pharmaceutical and biopharmaceutical preparations containing insulin for the treatment of diabetes; insulin injectors sold filled with insulin Medical apparatus used for the delivery of insulin, namely, insulin injectors sold empty; medical apparatus for the delivery of insulin to the body, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Medicinal, pharmaceutical and biopharmaceutical preparations for the treatment of diabetes; medicinal, pharmaceutical and biopharmaceutical preparations containing insulin for the treatment of diabetes; insulin injectors sold filled with insulin
Class [010]
Medical Instrument Products
Medical apparatus used for the delivery of insulin, namely, insulin injectors sold empty; medical apparatus for the delivery of insulin to the body, namely, insulin injectors sold empty
Mark Details
Serial Number
No 86772159
Mark Type
No Service/Collective Mark
Attorney Docket Number
No U2740-00041
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Oct 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 21st Oct 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 04th Apr 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 03rd Apr 2019 | EXTENSION 5 GRANTED |
| 07th Mar 2019 | EXTENSION 5 FILED |
| 07th Mar 2019 | TEAS EXTENSION RECEIVED |
| 19th Sep 2018 | ITU LETTER MAILED, NO RESPONSE REQUIRED |
| 19th Sep 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 12th Sep 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Sep 2018 | EXTENSION 4 GRANTED |